250 related articles for article (PubMed ID: 15949331)
1. [Specific antibodies against the nucleocapsid protein and S1 domain of spike glycoprotein in patients with severe acute respiratory syndrome].
Mei YB; Wang YD; Liao ZY; Hao W; Che XY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):526-9. PubMed ID: 15949331
[TBL] [Abstract][Full Text] [Related]
2. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients.
Wang Y; Chang Z; Ouyang J; Wei H; Yang R; Chao Y; Qu J; Wang J; Hung T
DNA Cell Biol; 2005 Aug; 24(8):521-7. PubMed ID: 16101351
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
[TBL] [Abstract][Full Text] [Related]
4. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-Baccalà G
Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
[TBL] [Abstract][Full Text] [Related]
5. [A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS].
Yan HP; Tan YF; Zhuang H; Zhou YS; Zhao CH; Feng X; Jin RH; Wu H; Fu Y
Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):896-9. PubMed ID: 17313874
[TBL] [Abstract][Full Text] [Related]
6. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
[TBL] [Abstract][Full Text] [Related]
8. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
[TBL] [Abstract][Full Text] [Related]
10. Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.
Giménez LG; Rojas J; Rojas A; Mendoza J; Camacho AG
Clin Vaccine Immunol; 2009 Feb; 16(2):241-5. PubMed ID: 19038782
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.
Zhao J; Wang W; Wang W; Zhao Z; Zhang Y; Lv P; Ren F; Gao XM
Clin Vaccine Immunol; 2007 Jul; 14(7):839-46. PubMed ID: 17475765
[TBL] [Abstract][Full Text] [Related]
13. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
[TBL] [Abstract][Full Text] [Related]
14. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.
Ayouba A; Thaurignac G; Morquin D; Tuaillon E; Raulino R; Nkuba A; Lacroix A; Vidal N; Foulongne V; Le Moing V; Reynes J; Delaporte E; Peeters M
J Clin Virol; 2020 Aug; 129():104521. PubMed ID: 32623350
[TBL] [Abstract][Full Text] [Related]
15. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
[TBL] [Abstract][Full Text] [Related]
16. [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome].
Shi YL; Li LH; Sun ZH; Chen JY; Liao Y; Zeng LL; Zhang W; Chen XD; Cao C
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):795-9. PubMed ID: 21162846
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
[TBL] [Abstract][Full Text] [Related]
18. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.
Zhong X; Yang H; Guo ZF; Sin WY; Chen W; Xu J; Fu L; Wu J; Mak CK; Cheng CS; Yang Y; Cao S; Wong TY; Lai ST; Xie Y; Guo Z
J Virol; 2005 Mar; 79(6):3401-8. PubMed ID: 15731234
[TBL] [Abstract][Full Text] [Related]
19. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid.
Leung DT; Tam FC; Ma CH; Chan PK; Cheung JL; Niu H; Tam JS; Lim PL
J Infect Dis; 2004 Jul; 190(2):379-86. PubMed ID: 15216476
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a reference panel for the detection of anti-SARS-CoV antibodies.
Liu C; Li X; Zhang C; Xu S; Shao Y; Zhuang H; Che X; Qiu Y; Yin H; Li D; Wang Y
Biologicals; 2007 Jun; 35(3):203-10. PubMed ID: 17261372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
